Đang chuẩn bị liên kết để tải về tài liệu:
Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Masitinib (MST) is an orally administered drug that targets mast cells and macrophages, important cells for immunity, by inhibiting a limited number of tyrosine kinases. It is currently registered in Europe and USA for the treatment of mast cell tumors in dogs. | Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry

TÀI LIỆU LIÊN QUAN

Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC–ESI–MS/MS

Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry

Báo cáo y học: "Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo"

Báo cáo khoa học: " Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo"

Progestins and the Mammary Gland From Basic Science to Clinical Applications

Báo cáo khoa học: Two types of replication protein A in seed plants Characterization of their functions in vitro and in vivo

Báo cáo Y học: Identification and characterization of the Escherichia coli stress protein UP12, a putative in vivo substrate of GroEL

A novel cold-adapted type I pullulanase of Paenibacillus polymyxa Nws-pp2: In vivo functional expression and biochemical characterization of glucans hydrolyzates analysis

Ultrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound

In vivo assessment of prostate cancer response using quantitative ultrasound characterization of ultrasonic scattering properties